Literature DB >> 7911183

Physiological importance of dehydroepiandrosterone.

P Ebeling1, V A Koivisto.   

Abstract

Dehydroepiandrosterone (DHEA), with its sulphate conjugate (DHEAS), is the most abundant steroid hormone in the circulation but its physiological importance is unclear. We propose that DHEA has either oestrogen-like or androgen-like effects depending on the hormonal milieu. In premenopausal women DHEA is either an oestrogen antagonist, perhaps through the competitive binding of its metabolite 5-androstene-3 beta, 17 beta-diol (ADIOL) and oestradiol to the oestrogen receptor, or an androgen through its metabolism to androstenedione and testosterone. In women DHEA contributes to abdominal obesity and insulin resistance: in the premenopausal high oestrogen concentrations may counterbalance the androgenic effects of DHEA but in the postmenopausal metabolism to testosterone may increase the risk of cardiovascular disease, though this effect may be counterbalanced by the age-dependent decline in DHEA and also by the oestradiol-like effects of ADIOL. In some breast cancer cell lines in a low oestrogen milieu DHEA has an oestradiol-like effect, stimulating tumour growth, whereas in oestradiol abundance DHEA antagonises the growth-stimulating effect of oestradiol. In men, with an androgenic milieu, DHEA acts like an oestrogen and protects against cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911183     DOI: 10.1016/s0140-6736(94)92587-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  54 in total

Review 1.  Gender dimorphism in immune responses following trauma and hemorrhage.

Authors:  Yukihiro Yokoyama; Martin G Schwacha; T S Anantha Samy; Kirby I Bland; Irshad H Chaudry
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

3.  Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels.

Authors:  E Mazza; M Maccario; J Ramunni; C Gauna; A Bertagna; A M Barberis; S Patroncini; M Messina; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

4.  Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women.

Authors:  S Savastano; A Belfiore; B Guida; L Angrisani; F Orio; T Cascella; F Milone; F Micanti; G Saldalamacchia; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

5.  Nipple Aspirate Fluid Hormone Concentrations and Breast Cancer Risk.

Authors:  Robert T Chatterton; Richard E Heinz; Angela J Fought; David Ivancic; Claire Shappell; Subhashini Allu; Susan Gapstur; Denise M Scholtens; Peter H Gann; Seema A Khan
Journal:  Horm Cancer       Date:  2016-02-22       Impact factor: 3.869

6.  The impact of a new emotional self-management program on stress, emotions, heart rate variability, DHEA and cortisol.

Authors:  R McCraty; B Barrios-Choplin; D Rozman; M Atkinson; A D Watkins
Journal:  Integr Physiol Behav Sci       Date:  1998 Apr-Jun

7.  Insulin analogues and carcinoma of the breast.

Authors:  P Ebeling; J A Tuominen; V A Koivisto
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

8.  Objective habitual physical activity and estradiol levels in obese Latina adolescents.

Authors:  Lauren E Gyllenhammer; Amanda K Vanni; Courtney E Byrd-Williams; Marc Kalan; Leslie Bernstein; Jaimie N Davis
Journal:  J Phys Act Health       Date:  2012-10-04

Review 9.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

10.  Plasma dehydroepiandrosterone and risk of myocardial infarction in women.

Authors:  John H Page; Jing Ma; Kathryn M Rexrode; Nader Rifai; Joann E Manson; Susan E Hankinson
Journal:  Clin Chem       Date:  2008-05-01       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.